Halozyme takes bigger loss on testing expenses

Full story: Bioscience Technology

Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Diabetes Discussions

Topic	Updated	Last By	Comments
Viagra Could Be Hiding Serious Risk For Heart D... (Sep '08)	29 min	Flavio	5
Byetta (Feb '06)	3 hr	Michael	2710
Medical Conditions that Cause Erectile Dysfunction (Nov '08)	16 hr	Godfarther	2
Closing of Dialysis Unit Hits Illegal Immigrant...	20 hr	Pug	13
Baby Boomers face more health problems than the...	21 hr	Anamouse	27
Looking to buy a used Insulin Pump (Nov '07)	Sun	notnow	440
MiniMed Paradigm 722 Insulin Pump for sale (Apr '08)	Sun	Wayne	36